en
Scientific article
Open access
English

Risk of MS relapse after yellow fever vaccination: A self-controlled case series

Published inNeurology: Neuroimmunology & Neuroinflammation, vol. 7, no. 4, e726
Publication date2020
Abstract

To determine whether live-attenuated yellow fever vaccine (YFV) was associated with MS relapse, we evaluated the clinical courses of 23 patients in the year before and the year after immunization at the university hospital of Geneva, Switzerland.

Citation (ISO format)
CSAKI HUTTNER, Angela et al. Risk of MS relapse after yellow fever vaccination: A self-controlled case series. In: Neurology: Neuroimmunology & Neuroinflammation, 2020, vol. 7, n° 4, p. e726. doi: 10.1212/NXI.0000000000000726
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2332-7812
149views
50downloads

Technical informations

Creation07/16/2021 3:04:00 PM
First validation07/16/2021 3:04:00 PM
Update time03/16/2023 12:59:28 AM
Status update03/16/2023 12:59:27 AM
Last indexation05/06/2024 7:52:01 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack